**7.8 Long-term monitoring**

Prolonged monitoring and follow-up evaluations of patients after successful treatment are recommended for relapse or recurrence of the disease. Yearly followup is recommended for patients infected with *L. braziliensis* for up to a decade for early detection of any progression to mucocutaneous disease. Certain complex cases of ML, diffuse CL, *L. recidivans*, and PKDL can be difficult to treat and may require prolonged therapy. In addition, retreatment and/or second-line medications may be required for patients with resistant disease.
